We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

217 hedge funds and large institutions have $1.1B invested in SANGAMO THERAPEUTICS INC in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 57

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

19% more capital invested

Capital invested by funds: $919M → $1.1B (+$178M)

3% more funds holding

Funds holding: 210 → 217 (+7)

0% more call options, than puts

Call options by funds: $36.1M | Put options by funds: $36M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 63.79% → 63.7% (-0.09%)

Holders
217
Holders Change
+7
Holders Change %
+3.33%
% of All Funds
4.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
74
Reduced
57
Closed
28
Calls
$36.1M
Puts
$36M
Net Calls
+$97K
Net Calls Change
+$2.61M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.5M
2
Goldman Sachs
Goldman Sachs
New York
+$9.13M
3
CC
Casdin Capital
New York
+$9.12M
4
WA
Wasatch Advisors
Utah
+$7.39M
5
Millennium Management
Millennium Management
New York
+$6.81M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$28.1M
2
EC
EcoR1 Capital
California
-$17.7M
3
NC
Nexthera Capital
New York
-$15.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
176
Huntington National Bank
Ohio
$34K +$30.4K +2,000 New
CWM
177
Cranbrook Wealth Management
Michigan
$27K +$24.6K +1,620 New
BWP
178
Baldwin Wealth Partners
Massachusetts
$25K – – –
AG
179
Advisor Group
Arizona
$25K +$7.6K +500 +53%
IP
180
Intellectus Partners
California
$25K +$22.8K +1,500 New
CHP
181
Cable Hill Partners
Oregon
$24K – – –
CG
182
Cutler Group
California
$21K – – –
FDCDDQ
183
Federation des caisses Desjardins du Quebec
Quebec, Canada
$20.3K +$18.2K +1,200 New
TRCT
184
Tower Research Capital (TRC)
New York
$20K +$1.5K +99 +9%
AF
185
Allworth Financial
California
$17K – – –
CWA
186
Clarus Wealth Advisors
Arizona
$17K – – –
RE
187
RBC Europe
United Kingdom
$16.9K – – –
APA
188
American Portfolios Advisors
New York
$15.7K – – –
KBC Group
189
KBC Group
Belgium
$14K – – –
MFW
190
Mosaic Family Wealth
Missouri
$11K – – –
APP
191
Avantax Planning Partners
Iowa
$10K +$9.21K +606 New
Nisa Investment Advisors
192
Nisa Investment Advisors
Missouri
$9K -$5.47K -360 -41%
BFC
193
Bedel Financial Consulting
Indiana
$9K – – –
TPWA
194
TRUE Private Wealth Advisors
Oregon
$8.47K +$7.6K +500 New
GWM
195
Geneos Wealth Management
Colorado
$8K -$15.2K -1,000 -67%
Daiwa Securities Group
196
Daiwa Securities Group
Japan
$8K – – –
PNC Financial Services Group
197
PNC Financial Services Group
Pennsylvania
$8K – – –
VIA
198
Vantage Investment Advisors
Pennsylvania
$8K – – –
IA
199
IFP Advisors
Florida
$8K +$5.78K +380 +317%
WT
200
Whittier Trust
California
$6K – – –
6 7
8
9 10

SGMO Hedge Fund Activity: Q3 2018 in Review

217 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2018, worth a combined $1.1B — up 19% from $919M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 28 closed out — a net gain of 7 holders — while 74 added to existing stakes and 57 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $15.5M. The largest seller was Adage Capital Partners, cutting an estimated $28.1M.

  • 217 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2018, up from 210 in Q2 2018.
  • Funds reported $1.1B of SANGAMO THERAPEUTICS INC stock for Q3 2018, up 19% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2018 and 28 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2018 was Wellington Management Group, an estimated $15.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2018 was Adage Capital Partners, an estimated $28.1M sold.

Based on aggregated 13F filings for Q3 2018.